Page
%P
![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessAntioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer
To explore the mechanisms of radiotherapy resistance and search for prognostic biomarkers for prostate cancer.
-
Article
Open AccessSingle-cell sequencing reveals MYC targeting gene MAD2L1 is associated with prostate cancer bone metastasis tumor dormancy
Among malignant tumors, bone metastasis is frequently associated with prostate cancer which is seen in about 80% of patients. During cancer treatments, some tumor cells switch to a "dormant mode" to help tumor...